Literature DB >> 19208751

HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression.

Jiaxiang Ji1, Miles W Cloyd.   

Abstract

The establishment and persistence of many chronic infections have been demonstrated to depend on restraint of the vigor of the anti-microbial immune responses by CD4+CD25+ regulatory T (Treg) cells. In HIV-infected individuals, Treg cells suppress both HIV-specific and general CD4+ and CD8+ T cell responses. Increases of CD4+CD25+ Treg cell function during viral infections might be mediated by host-derived pro-inflammatory molecules or directly by viral infection or binding. We examined the effect HIV has upon binding to CD4+CD25+ Treg cells by exposing human purified CD4+CD25+ T cells from healthy donors to HIV-1 in vitro and assessing their Treg-associated functional marker profile and suppressive activities. We found that HIV-1 binding increased their suppressor activities by 2- to 5-fold, which was accompanied by enhanced expression of Treg-associated functional markers sCTLA-4, glucocorticoid-induced tumor necrosis factor receptor and FoxP3. Moreover, HIV-1 binding extended the survival of CD4+CD25+ Treg cells and up-regulated the expression of homing receptors CD62L and integrin alpha4beta7, which in turn would result in Treg cells migrating more rapidly to the peripheral lymph nodes and mucosal lymphoid tissues where anti-HIV immune responses are occurring. Importantly, CD4+CD25+ Treg cells exposed to HIV were not susceptible to homing-induced apoptosis like are other resting CD4+ cells following HIV-1 binding. We show that CD4+CD25+ Treg cells respond directly to HIV-1 itself through HIV gp120 interactions with CD4 molecules. Collectively, our findings explain a mechanism that contributes to the abnormal accumulation of intensified Treg cells in lymphoid and mucosal tissues in HIV patients, resulting in impairment of immune responses which would greatly help HIV persistence.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19208751      PMCID: PMC2645780          DOI: 10.1093/intimm/dxn146

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  80 in total

Review 1.  Natural versus adaptive regulatory T cells.

Authors:  Jeffrey A Bluestone; Abul K Abbas
Journal:  Nat Rev Immunol       Date:  2003-03       Impact factor: 53.106

Review 2.  Natural regulatory T cells in infectious disease.

Authors:  Yasmine Belkaid; Barry T Rouse
Journal:  Nat Immunol       Date:  2005-04       Impact factor: 25.606

3.  Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART.

Authors:  Hans-Jörg Epple; Christoph Loddenkemper; Desirée Kunkel; Hanno Tröger; Jochen Maul; Verena Moos; Erika Berg; Reiner Ullrich; Jörg-Dieter Schulzke; Harald Stein; Rainer Duchmann; Martin Zeitz; Thomas Schneider
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

4.  FOXP3 mRNA levels are decreased in peripheral blood CD4+ lymphocytes from HIV-positive patients.

Authors:  Pol André Apoil; Bénédicte Puissant; Francis Roubinet; Michel Abbal; Patrice Massip; Antoine Blancher
Journal:  J Acquir Immune Defic Syndr       Date:  2005-08-01       Impact factor: 3.731

5.  CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection.

Authors:  Jiaxiang Ji; Joseph Masterson; Jiaren Sun; Lynn Soong
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

6.  HIV-1 induces IL-10 production in human monocytes via a CD4-independent pathway.

Authors:  Jiaxiang Ji; Gautam K Sahu; Vivian L Braciale; Miles W Cloyd
Journal:  Int Immunol       Date:  2005-06-03       Impact factor: 4.823

7.  HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

Authors:  Jakob Nilsson; Adriano Boasso; Paula Andrea Velilla; Rui Zhang; Monica Vaccari; Genoveffa Franchini; Gene M Shearer; Jan Andersson; Claire Chougnet
Journal:  Blood       Date:  2006-08-10       Impact factor: 22.113

8.  The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.

Authors:  Jan Andersson; Adriano Boasso; Jakob Nilsson; Rui Zhang; Norah J Shire; Stefan Lindback; Gene M Shearer; Claire A Chougnet
Journal:  J Immunol       Date:  2005-03-15       Impact factor: 5.422

9.  Molecular mechanisms underlying FOXP3 induction in human T cells.

Authors:  Pierre-Yves Mantel; Nadia Ouaked; Beate Rückert; Christian Karagiannidis; Roland Welz; Kurt Blaser; Carsten B Schmidt-Weber
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

10.  Foxp3 represses retroviral transcription by targeting both NF-kappaB and CREB pathways.

Authors:  Christian Grant; Unsong Oh; Kazunori Fugo; Norihiro Takenouchi; Caitlin Griffith; Karen Yao; Timothy E Newhook; Lee Ratner; Steven Jacobson
Journal:  PLoS Pathog       Date:  2006-04-28       Impact factor: 6.823

View more
  29 in total

Review 1.  Harnessing regulatory T cells to suppress asthma: from potential to therapy.

Authors:  Alison N Thorburn; Philip M Hansbro
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-22       Impact factor: 6.914

2.  Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.

Authors:  Julia M Shaw; Peter W Hunt; J William Critchfield; Delandy H McConnell; Juan Carlos Garcia; Richard B Pollard; Ma Somsouk; Steven G Deeks; Barbara L Shacklett
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

3.  Role played by CD4+FOXP3+ regulatory T Cells in suppression of host responses to Haemophilus ducreyi during experimental infection of human volunteers.

Authors:  Wei Li; Klara Tenner-Racz; Paul Racz; Diane M Janowicz; Kate R Fortney; Barry P Katz; Stanley M Spinola
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 4.  Homeostasis and function of regulatory T cells in HIV/SIV infection.

Authors:  Maria E Moreno-Fernandez; Pietro Presicce; Claire A Chougnet
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

5.  Altered phenotype of regulatory T cells associated with lack of human immunodeficiency virus (HIV)-1-specific suppressive function.

Authors:  C T Burton; S J Westrop; I Eccles-James; A Boasso; M R Nelson; M Bower; N Imami
Journal:  Clin Exp Immunol       Date:  2011-11       Impact factor: 4.330

6.  Human immunodeficiency virus infection and autoimmune hepatitis during highly active anti-retroviral treatment: a case report and review of the literature.

Authors:  Hanady Daas; Riad Khatib; Haitham Nasser; Farah Kamran; Martha Higgins; Louis Saravolatz
Journal:  J Med Case Rep       Date:  2011-06-25

7.  Human immunodeficiency virus type 1 gp120 reprogramming of CD4+ T-cell migration provides a mechanism for lymphadenopathy.

Authors:  Daniel S Green; David M Center; William W Cruikshank
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Increased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infection.

Authors:  Georgina Thorborn; Laura Pomeroy; Heidi Isohanni; Melissa Perry; Barry Peters; Annapurna Vyakarnam
Journal:  PLoS One       Date:  2010-02-17       Impact factor: 3.240

Review 9.  Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors:  Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 10.  Role of the Fas/FasL pathway in HIV or SIV disease.

Authors:  Bhawna Poonia; C David Pauza; Maria S Salvato
Journal:  Retrovirology       Date:  2009-10-15       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.